drugset / Trial / NCT01865201

Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis

NCT01865201

RandomizedParallel-groupOpen-labelTreatment

Summary

It is hypothesized that excessive generation of free radicals involves in the pathogenesis of radiation-induced brain necrosis. This study therefore evaluated the effect of free radical scavenger, edaravone, on radiation-induced temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after radiotherapy.

Timeline

Start
2009-03
Primary completion
2011-10
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Edaravone Unknown 30 mg Intravenous